Member Info for c2645sg

.....and here come all the (filtered) paid rampers.

-War with Russia,
-Inflation going towards 10%
-Interest rates on the way up so AML's debt ballooning
-cash balance built on sand
-court case which could bankrupt them

Who would want to buy this now?

You ramble all you want

Tony are you Stroll in disguise? haha.

In a week, all we will know is what the company wants us to know.

I bet original holders are sweating now, only just breaking even.....
They will all say they are buying more, while secretly dumping their stock, imho.

It confirms what my source is telling me. No way would I post that info online first.

If it's true, it ties in perfectly with everything else....
Cash balance is mainly Valkyrie deposits. The Valkyrie is an omni-shambles of a clusterfeck, and the CFO didn't like the fact that cash balance was something that unhappy customers will ultimately demand back. Either because it doesn't work or will take YEARS to produce and deliver them all.
Seemingly the reason for the track car was to tease the road car buyers across, as the chances of it ever working are slim. Oh dear.

AML have told the world they have shipped 10 Valkyries in 2021 to stop the hole in the balance sheet, just like I stated months ago.
Now it turns out they *might* have been economical with the truth and only delivered the prototypes to dealers and no customer has a working version.

Stroll is taking a HUGE gamble here. In pure desperation.

Wow, that's how it's calculated.... Tranche 2 is expected within next 6 weeks and the weighted average for the last 4 weeks is well under £12.46, MORE cash required to compensate Merc.

If, at the time of issue of the Tranche 2 Consideration Shares or the Tranche 3 Consideration
Shares, the volume weighted average price of the Ordinary Shares for the 30 consecutive trading
days that are two business days prior to the date of issue of the Tranche 2 Consideration Shares
or the Tranche 3 Consideration Shares (as applicable) (the “Reference Price”) is lower than the
MBAG Entry Price, the Company will make an additional cash payment to MBAG in an amount
equal to the difference between the MBAG Entry Price and the Reference Price multiplied by the
number of the Tranche 2 Consideration Shares or the Tranche 3 Consideration Shares (as
applicable) that has been issued to MBAG

• if, following the issue to MBAG of the Tranche 2 Consideration Shares, the Tranche 1 Valuation Amount and the Tranche 2 Valuation Amount are, in aggregate, less than the Aggregate MBAG Consideration Amount agreed in the Strategic Cooperation Agreement, the Company and MBAG shall, during the Company’s financial year ending 31 December 2022, agree the scope and value of further MBAG Technology that the Group will be provided access to over the course of that year (the “Phase 3 Technology”), which shall, subject to the specific commercial terms of supply being finalised, be documented between them (or their respective subsidiaries) in further Operational Agreements. The aggregate value of such Phase 3 Technology, when taken together with the Tranche 1 Valuation Amount and the Tranche 2 Valuation Amount (together, the “Aggregate Technology Valuation Amount”), shall be no less than the Aggregate MBAG Consideration Amount; • as soon as the Aggregate Technology Valuation Amount is equal to or exceeds the Aggregate MBAG Consideration Amount, which in any event shall be by no later than the first quarter of 2023, the Company shall issue the final tranche of Consideration Shares to MBAG (the “Tranche 3 Consideration Shares”); and • all Consideration Shares that have been agreed to be issued to MBAG in connection with the Strategic Cooperation shall be issued to it by no later than the first quarter of 2023.

If, following the issue of the Tranche 2 Consideration Shares or the Tranche 3 Consideration Shares (as relevant), the aggregate value of all MBAG Technology that the Company has been provided access to at such time is greater than the Aggregate MBAG Consideration Amount, the Company shall make MBAG whole for this shortfall by making an additional cash payment of an equivalent amount to MBAG (a “Cash Top-up”). The ability of the Company to make any Cash Top-up payments to MBAG, either after the issue of the Tranche 2 Consideration Shares or after the issue of the Tranche 3 Consideration Shares, is subject to a maximum cap of £28.6 million, being 10 per cent. of the Aggregate MBAG Consideration Amount.

By no later than the first quarter of 2022, the Company shall issue to MBAG additional Consideration Shares (the “Tranche 2 Consideration Shares”), the aggregate value of which (by reference to the MBAG Entry Price) shall be equivalent to the aggregate value of all Phase 2 Technology that has been agreed in the Operational Agreements relating to such technology (the “Tranche 2 Valuation Amount”);

• as soon as the Aggregate Technology Valuation Amount is equal to or exceeds the Aggregate MBAG Consideration Amount, which in any event shall be by no later than the first quarter of 2023, the Company shall issue the final tranche of Consideration Shares to MBAG (the “Tranche 3 Consideration Shares”); and • all Consideration Shares that have been agreed to be issued to MBAG in connection with the Strategic Cooperation shall be issued to it by no later than the first quarter of 2023.

• if, following the issue to MBAG of the Tranche 2 Consideration Shares, the Tranche 1 Valuation Amount and the Tranche 2 Valuation Amount are, in aggregate, less than the Aggregate MBAG Consideration Amount agreed in the Strategic Cooperation Agreement, the Company and MBAG shall, during the Company’s financial year ending 31 December 2022, agree the scope and value of further MBAG Technology that the Group will be provided access to over the course of that year (the “Phase 3 Technology”), which shall, subject to the specific commercial terms of supply being finalised, be documented between them (or their respective subsidiaries) in further Operational Agreements. The aggregate value of such Phase 3 Technology, when taken together with the Tranche 1 Valuation Amount and the Tranche 2 Valuation Amount (together, the “Aggregate Technology Valuation Amount”), shall be no less than the Aggregate MBAG Consideration Amount; • as soon as the Aggregate Technology Valuation Amount is equal to or exceeds the Aggregate MBAG Consideration Amount, which in any event shall be by no later than the first quarter of 2023, the Company shall issue the final tranche of Consideration Shares to MBAG (the “Tranche 3 Consideration Shares”); and • all Consideration Shares that have been agreed to be issued to MBAG in connection with the Strategic Cooperation shall be issued to it by no later than the first quarter of 2023.

Check the comments section.
Ooooooft, Valkyrie recall.

...and here's also proof of the 5% warrant dilution.
It pays to read and understand everything, otherwise you're just gambling,. which most on here are.

Prospective issued share capital impacts

Current issued share capital as the date of this announcement 1,824,014,450 shares

Proposed placing shares 250,000,000 shares

First tranche of Consideration Shares 224,657,287 shares

Expected issued share capital following General Meeting 2,298,671,737 shares

Future issuance(s) of Consideration Shares 234,285,457 shares

New Financing warrants Convertible into new shares 126,647,852 shares

Pro-Forma issued share capital 2,659,605,046 shares

The tech deal only runs until 2027, if I were Merc I would be holding tight and cutting another deal in 2025/6 for another 15/20% of the company for free.
Aml/Stroll need Merc like a fish needs water, so Merc are in 100% control here. Why buy something when you can get it for free?

I guess I'll do your homework for you then....

"· No later than by early 2022, Aston Martin expects to issue further Consideration Shares to Mercedes-Benz AG, reflecting the value of the second technology basket received at that time, which will be mainly focused on battery electric vehicle technology. Aston Martin may continue to receive access to additional technology throughout 2022, in return for issuing additional Consideration Shares to Mercedes-Benz AG, until the total value of all Consideration Shares issued reaches £286 million. If the ordinary share trading price on the date any further Consideration Shares (beyond the first issue) are issued is below the Mercedes-Benz AG Entry Price, Aston Martin will be required to compensate Mercedes-Benz AG for the difference between the two prices by making a further cash payment (on a per share basis).

· If the value of such access to technology surpasses the total value of Consideration Shares being issued, Aston Martin will top Mercedes-Benz AG up with a cash payment, subject to a maximum cap of £28.6m.

· All Consideration Shares are expected to have been issued by no later than early 2023."

Merc aint paying anything. They are getting 10% for free through new shares.
I am fairly sure the time limit is early 2023, but not 100% exactly when that is.

Why would there be a renegotiation when they are getting a free ride?

Merc still haven't even got their next free batch of shares, 10% is due to them before 2023.
They are hardly going to say no.
I don't see the share price going much above this area with high inflation and a 10% dilution. (plus another 5% dilution in warrants too)

What about circumstances like war with Russia, Moers leaving or losing the court case? Still think it will stay above £10?

I think everyone can ignore just about anything you say.

Posted in: AML
Posts: 98
Price: 46.20
No Opinion
F1 Practice03 Jul 2020 14:36

A positive note.

Aston Martins first season in F1 is going to be sensational. They will be running the same spec of car next season as this and the car is (Baby Merc) is looking extremely competitive.

I couldn't care less.
You said it would double and it halved.
That's why we should ignore people like you who say the SP will double without any facts/figures.
Which is exactly what I will do, thanks.

You thought the AML SP would double, in fact it has halved. :(

That's what happens when you ignore the people who know stuff and listen to the idiots who have no clue, or lie and ramp to suit their agenda.
Your choice, I thought the market was there to make money, not throw it away.

KiteFlying
Posted in: AML
Posts: 98
Price: 1,995.00
No Opinion

Honesty13 Apr 2021 21:24
So much ****e written on here by certain individuals. Don’t know what there game is or their aims. I only have 1000 shares unlike some of you that have buckets piled in or others that have fewer. Either way the last year has been a great investment and I am sure it will go down and up over the next few months. This time next year though I can only see it doubling like it has the last year. Could have put the money in the bank and ... no I don’t need to say anymore

NOVEMBER this was written.
You all knew about it then because I posted it.
Multimatic are a small company who CANNOT manufacture a few at a time.
Prove me wrong Son of Swiss, let's see some evidence then can make more than 1 at a time.
I'll keep calling people liars who are. Thanks.

https://amlbonddb5news.wordpress.com/2021/11/12/weekly-news-about-tech-investing-and-the-digital-age/

Carpy, Moers either lied (more probably as he knew what was going on with the Multimatic suppliers at the time, as was I who posted it on here and got laughed at again) or was negligent in not knowing how long it took to build a carbon fibre tub.

Either way, it's another profit warning waiting to happen. Some owners will be waiting years to get their Valkyrie.
Imagine some of them start asking for their deposit back.
What a mess.

There are 260 Valkyries due to be built. Let's just say it takes 1 month to build each tub, well, you can do the math. Way more than 5 years....
No wonder Stroll was looking to replace Moers.

It's not making the car, it's the suppliers with the carbon fibre tubs. Making them takes 6-8 weeks.
Some people don't like facts it seems, even in the FT.

TinyPie, still waiting to hear where they are getting the cash to buy back the bonds.